Cat. #151618
Anti-MMP1 [3B6]
Cat. #: 151618
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Human matrix metalloproteinase 1 (MMP-1)
Class: Monoclonal
Application: IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Ayham Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-MMP1 [3B6]
- Clone: 3B6
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IHC ; IF ; IP ; WB
- Description: MMP1 cleaves collagens of types I, II, and III at one site in the helical domain. MMP1 also cleaves collagens of types VII and X. In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity.
- Immunogen: Ovalbumin-conjugated synthetic peptide; CSSFGFPRTVKH
- Isotype: IgG1
- Myeloma used: P3X63Ag8.653
- Recommended controls: IHC: formalin-fixed, paraffin-embedded colonic adenocarcinomaWestern blot: rhMMP-1, 400 ng per lane
Target Details
- Target: Human matrix metalloproteinase 1 (MMP-1)
- Tissue cell line specificity: IHC: formalin-fixed, paraffin-embedded colonic adenocarcinomaWestern blot: rhMMP-1, 400 ng per lane
- Target background: MMP1 cleaves collagens of types I, II, and III at one site in the helical domain. MMP1 also cleaves collagens of types VII and X. In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity.
Applications
- Application: IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -80° C
- Shipping conditions: Shipping at 4° C
References
- Jeffery et al. 2009. Histopathology. 54(7):820-8. PMID: 19635101.
- The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
- Lyall et al. 2006. Clin Cancer Res. 12(4):1184-91. PMID: 16489072.
- Profiling markers of prognosis in colorectal cancer.
- Curran et al. 2004. Clin Cancer Res. 10(24):8229-34. PMID: 15623598.
- Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
- Murray et al. 1998. Gut. 43(6):791-7. PMID: 9824606.
- Matrix metalloproteinases and their inhibitors in gastric cancer.
- Murray et al. 1998. J Pathol. 185(3):256-61. PMID: 9771478.
- Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
- Murray et al. 1996. Nat Med. 2(4):461-2. PMID: 8597958.
- Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.
